Score Overview
Charles River Laboratories fundamental performance
Between 2015 and 2025, revenue grew from $ 1.36B to $ 4.01B and net income went from $ 149M to -$ 144M. Revenue increased in 7 of those 10 years; net income in 5.
Across Charles River Laboratories's full reported history, from 2000 to 2025, revenue grew from $ 306M to $ 4.01B and net income went from -$ 11M to -$ 144M. Revenue increased in 73% of the years measured; net income in 65%.
Charles River Laboratories currently holds a 20-year HDB Score of 4.3 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-13 | $ 281.27 | — |
1 Year2025-08-13 | $ 155.00 | 81.46% |
5 Years2021-08-13 | $ 411.22 | -31.60% |
10 Years2016-08-12 | $ 82.92 | 239.21% |
20 Years2006-08-11 | $ 38.03 | 7x |
All Time2000-06-23 | $ 22.00 | 12x |
| Period | Last Price2026-08-13 | 1 Year2025-08-13 | 5 Years2021-08-13 | 10 Years2016-08-12 | 20 Years2006-08-11 | All Time2000-06-23 |
|---|---|---|---|---|---|---|
| Price | $ 281.27 | $ 155.00 | $ 411.22 | $ 82.92 | $ 38.03 | $ 22.00 |
| Return | — | 81.46% | -31.60% | 239.21% | 7x | 12x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 3.99B | -$ 238M | $ 192M |
| 2025 | $ 4.01B | -$ 144M | $ 213M |
| 2024 | $ 4.04B | $ 10M | $ 194M |
| 2023 | $ 4.12B | $ 474M | $ 276M |
| 2022 | $ 3.97B | $ 486M | $ 233M |
| 2021 | $ 3.54B | $ 390M | $ 246M |
| 2020 | $ 2.92B | $ 364M | $ 229M |
| 2019 | $ 2.62B | $ 252M | $ 238M |
| 2018 | $ 2.26B | $ 226M | $ 195M |
| 2017 | $ 1.85B | $ 123M | $ 163M |
| 2016 | $ 1.68B | $ 154M | $ 117M |
| 2015 | $ 1.36B | $ 149M | $ 117M |
| 2014 | $ 1.29B | $ 126M | $ 160M |
| 2013 | $ 1.16B | $ 102M | $ 155M |
| 2012 | $ 1.12B | $ 97M | $ 109M |
| 2011 | $ 1.14B | $ 109M | $ 68M |
| 2010 | $ 1.13B | -$ 336M | $ 188M |
| 2009 | $ 1.20B | $ 114M | $ 182M |
| 2008 | $ 1.34B | -$ 521M | $ 243M |
| 2007 | $ 1.23B | $ 154M | $ 240M |
| 2006 | $ 1.05B | -$ 55M | $ 182M |
| 2005 | $ 1.12B | $ 141M | $ 116M |
| 2004 | $ 766M | $ 89M | $ 207M |
| 2003 | $ 613M | $ 80M | $ 195M |
| 2002 | $ 554M | $ 50M | $ 122M |
| 2001 | $ 465M | $ 35M | $ 58M |
| IPO2000 | $ 306M | -$ 11M | $ 33M |
Explore beyond CRL
You're looking at Charles River Laboratories. Members apply the same fundamental framework across all 3,859 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,859 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
